2020 annual financial data
4D Molecular Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -374%.
Operating income was -56,664,000 USD and net income was -56,693,000 USD.
Operating cash flow was -50,909,000 USD.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,612,000 USD
- Operating income
- -56,664,000 USD
- Net income
- -56,693,000 USD
- Operating cash flow
- -50,909,000 USD